Tagged with

Hong Kong Professor James Chim, chairman and founder of the Hong Kong Society of Myeloma, shares the history and key objectives of the organization. He also elaborates on the recent milestones achieved regarding the treatment of the rare disease. Can you begin by introducing the Hong Kong Society of Myeloma and what…

Cyprus Vakis Frangos, managing director for commercial operations at Delorbis, walks us through the unique history of the company as one of the few local manufacturers in the island as well as his strategic vision to strengthen Delorbis’ brand on the global scene. After four years of existence, Delorbis is already…

Cannabis In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the cultivation and provision of medical cannabis.   The Republic will grant two 15-year licenses to private medical cannabis cultivators to…

Algeria Head of the Algerian National Laboratory for the Control of Pharmaceutical Products (LNCPP), an institution he helped found in 1995, Abdelaziz Gharbi describes the LNCPP’s journey, his great motivation to see international collaboration grow, and the role that Algeria can play in a context of regional influence. Last year saw…

Cyprus Mario Sciberras, former general manager for Malta and Gibraltar became general manager for Cyprus, Malta, and Gibraltar in 2016. In this interview, he touches on themes of transparency, GSK’s positioning on the market and its vaccination strategy for the coming years. What have been your main priorities since taking over…

Algeria Loic Galmard discusses the opportunities and challenges of setting up local production in Algeria, and the best strategies to increase market access and create a dialogue with the regulatory authorities. What are your first impressions of the local market in the 10 months that you have been here so far?…

Hong Kong Hye-ja Kim, Pfizer Pharmaceutical Innovative Health (Hong Kong and Macau Lead), shares how Pfizer’s global achievements in 2017 are reflected within the Hong Kong affiliate, the innovative solutions they can offer Hong Kong patients, government and other healthcare stakeholders beyond just a drug, and their continued commitment to extending their…

Hong Kong Dr. Sze-fai YIP, Chairman of the Hong Kong Society of Haematology (HKSH), shares the mission of the society to support healthcare professionals and other stakeholders within the area of haematology in order to drive better health outcomes, the challenges faced by haematology patients in Hong Kong, and the potential of…

Algeria Amine Sekhri, country manager for Roche Algeria discusses the potential for personalized precision medicine in Algeria and Roche’s important position within the Algerian market Could you please start by introducing yourself to our readers? This is actually my first role as a country manager. I am a physician, started my…

Regulation Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMMS) for PharmaBoardroom. Today more Canadians are dying in this crisis than at the height of the HIV epidemic. Recognizing that we need to join forces to fight the opioid epidemics in both our nations, Canadians…

brexit Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process. After the UK’s recent divorce from the EMA, officials are in unknown territory. With only six months until the UK leaves the EU, the UK government has advised drug makers to stockpile…

Global The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations…